Page last updated: 2024-10-28

lidocaine and Severe Dengue

lidocaine has been researched along with Severe Dengue in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Severe Dengue: A virulent form of dengue characterized by THROMBOCYTOPENIA and an increase in vascular permeability (grades I and II) and distinguished by a positive pain test (e.g., TOURNIQUET PAIN TEST). When accompanied by SHOCK (grades III and IV), it is called dengue shock syndrome.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Promphan, W1
Sopontammarak, S1
Pruekprasert, P1
Kajornwattanakul, W1
Kongpattanayothin, A1

Other Studies

1 other study available for lidocaine and Severe Dengue

ArticleYear
Dengue myocarditis.
    The Southeast Asian journal of tropical medicine and public health, 2004, Volume: 35, Issue:3

    Topics: Adolescent; Anti-Arrhythmia Agents; Bradycardia; Electrocardiography; Epinephrine; Heart Rate; Human

2004